These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30022055)

  • 1. Serum vascular adhesion protein-1 is up-regulated in hyperglycemia and is associated with incident diabetes negatively.
    Kuo CH; Wei JN; Yang CY; Ou HY; Wu HT; Fan KC; Wang SH; Hua CH; Hsiao CH; Lee MK; Li HY
    Int J Obes (Lond); 2019 Mar; 43(3):512-522. PubMed ID: 30022055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Visceral Adiposity Measurements, Metabolic and Inflammatory Profi le in Obese Patients with and Without Type 2 Diabetes Mellitus: A Crosssectional Analysis.
    Wanderley Rocha DR; Jorge AR; Braulio VB; Arbex AK; Marcadenti A
    Curr Diabetes Rev; 2017; 13(1):11-18. PubMed ID: 26467189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia.
    Li HY; Wei JN; Lin MS; Smith DJ; Vainio J; Lin CH; Chiang FT; Shih SR; Huang CH; Wu MY; Hsein YC; Chuang LM
    Clin Chim Acta; 2009 Jun; 404(2):149-53. PubMed ID: 19336232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum vascular adhesion protein-1 correlates with vascular endothelial growth factor in patients with type II diabetes.
    Yoshikawa N; Noda K; Shinoda H; Uchida A; Ozawa Y; Tsubota K; Mashima Y; Ishida S
    J Diabetes Complications; 2013; 27(2):162-6. PubMed ID: 23062326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-, sex- and glucose-dependent correlation of plasma soluble vascular adhesion protein-1 concentration with cardiovascular risk factors and subclinical atherosclerosis.
    Chen DW; Jin Y; Zhao RM; Long LJ; Zhang J; Han CL; Roivainen A; Knuuti J; Jalkanen S; Wang JC
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1544-58. PubMed ID: 27160127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Angiopoietin-like Protein 6, Risk of Type 2 Diabetes, and Response to Hyperglycemia: A Prospective Cohort Study.
    Fan KC; Wu HT; Wei JN; Chuang LM; Hsu CY; Yen IW; Lin CH; Lin MS; Shih SR; Wang SH; Chang TJ; Li HY
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32123920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular Adhesion Protein-1 (VAP-1) as Predictor of Radiographic Severity in Symptomatic Knee Osteoarthritis in the New York University Cohort.
    Bournazou E; Samuels J; Zhou H; Krasnokutsky S; Patel J; Han T; Bencardino J; Rybak L; Abramson SB; Junker U; Brown KS; Attur M
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation among soluble receptors for advanced glycation end-products, soluble vascular adhesion protein-1/semicarbazide-sensitive amine oxidase (sVAP-1) and cardiometabolic risk markers in apparently healthy adolescents: a cross-sectional study.
    Gurecká R; Koborová I; Csongová M; Šebek J; Šebeková K
    Glycoconj J; 2016 Aug; 33(4):599-606. PubMed ID: 27300745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases.
    Kurkijärvi R; Adams DH; Leino R; Möttönen T; Jalkanen S; Salmi M
    J Immunol; 1998 Aug; 161(3):1549-57. PubMed ID: 9686623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Vascular Adhesion Protein-1 Predicts End-Stage Renal Disease in Patients with Type 2 Diabetes.
    Li HY; Lin HA; Nien FJ; Wu VC; Jiang YD; Chang TJ; Kao HL; Lin MS; Wei JN; Lin CH; Shih SR; Hung CS; Chuang LM
    PLoS One; 2016; 11(2):e0147981. PubMed ID: 26845338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
    Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Change of serum vascular adhesion protein-1 after glucose loading correlates to carotid intima-medial thickness in non-diabetic subjects.
    Li HY; Lin MS; Wei JN; Hung CS; Chiang FT; Lin CH; Hsu HC; Su CY; Wu MY; Smith DJ; Vainio J; Chen MF; Chuang LM
    Clin Chim Acta; 2009 May; 403(1-2):97-101. PubMed ID: 19361461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma soluble vascular adhesion protein-1 concentration correlates with arterial stiffness: A cross-sectional study.
    Chen DW; Zhao RM; Jin Y; Zhang J; Han C; Jiang SQ; Zheng HF; Wang JC
    Arch Gerontol Geriatr; 2015; 61(1):67-71. PubMed ID: 25959807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble vascular adhesion protein-1 correlates with cardiovascular risk factors and early atherosclerotic manifestations.
    Aalto K; Maksimow M; Juonala M; Viikari J; Jula A; Kähönen M; Jalkanen S; Raitakari OT; Salmi M
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):523-32. PubMed ID: 22116093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes.
    Li HY; Jiang YD; Chang TJ; Wei JN; Lin MS; Lin CH; Chiang FT; Shih SR; Hung CS; Hua CH; Smith DJ; Vanio J; Chuang LM
    Diabetes; 2011 Mar; 60(3):993-9. PubMed ID: 21282368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating form of human vascular adhesion protein-1 (VAP-1): decreased serum levels in progression of colorectal cancer and predictive marker of lymphatic and hepatic metastasis.
    Toiyama Y; Miki C; Inoue Y; Kawamoto A; Kusunoki M
    J Surg Oncol; 2009 May; 99(6):368-72. PubMed ID: 19204971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postload hyperglycemia is associated with increased subclinical inflammation in patients with prediabetes.
    Colak A; Akinci B; Diniz G; Turkon H; Ergonen F; Yalcin H; Coker I
    Scand J Clin Lab Invest; 2013 Aug; 73(5):422-7. PubMed ID: 23767858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble vascular adhesion protein-1 predicts incident major adverse cardiovascular events and improves reclassification in a finnish prospective cohort study.
    Aalto K; Havulinna AS; Jalkanen S; Salomaa V; Salmi M
    Circ Cardiovasc Genet; 2014 Aug; 7(4):529-35. PubMed ID: 24850810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating soluble vascular adhesion protein 1 in patients with inflammatory bowel disease.
    Koutroubakis IE; Petinaki E; Vardas E; Dimoulios P; Roussomoustakaki M; Maniatis AN; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):405-8. PubMed ID: 11943954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identical anthropometric characteristics of impaired fasting glucose combined with impaired glucose tolerance and newly diagnosed type 2 diabetes: anthropometric indicators to predict hyperglycaemia in a community-based prospective cohort study in southwest China.
    Zhang F; Wan Q; Cao H; Tang L; Li D; Lü Q; Yan Z; Li J; Yang Q; Zhang Y; Tong N
    BMJ Open; 2018 May; 8(5):e019735. PubMed ID: 29743321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.